Bupropion-Associated Cardiovascular Effects

Introduction to Cardiovascular Risks

The FDA recommends monitoring blood pressure and heart rate, particularly during the first 12 weeks of bupropion treatment, as it can cause tachycardia and elevated heart rate, according to the American College of Cardiology guidelines 1.

When combined with naltrexone, cardiovascular monitoring becomes more critical, requiring periodic blood pressure and heart rate monitoring, especially during the first 12 weeks, as recommended by the American Heart Association 1.
Patients with uncontrolled hypertension should not receive bupropion, as the medication can elevate both blood pressure and heart rate, according to the American College of Physicians guidelines 2.

The 2024 American Heart Association guidelines note that psychostimulants like methylphenidate carry monitoring requirements for tachycardia and hypertension, but bupropion is not specifically flagged with the same level of cardiovascular concern as tricyclic antidepressants or SNRIs at high doses, with a strength of evidence rated as moderate 4.

Check baseline blood pressure and heart rate before initiating bupropion, and monitor periodically during treatment, with increased vigilance during the first 12 weeks, as recommended by the American College of Cardiology 1.
Monitor blood pressure and heart rate periodically during treatment, with increased vigilance during the first 12 weeks, particularly for patients on naltrexone-bupropion combinations, according to the American Heart Association guidelines 1.

The 2008 American College of Physicians guidelines note that while evidence on cardiovascular risks with second-generation antidepressants is scarce, weak evidence suggests venlafaxine may be associated with increased cardiovascular events, but similar concerns are not highlighted for bupropion, with a strength of evidence rated as low 5.

Administer the second dose of bupropion SR before 3 PM to minimize insomnia risk, which could indirectly affect heart rate through anxiety or sleep disturbance, as recommended by the American Academy of Sleep Medicine 2.
Patients with anxiety disorders may experience increased heart rate from anxiety exacerbation rather than direct drug effect, though bupropion efficacy is not significantly affected by comorbid anxiety, according to the American Psychiatric Association guidelines 2.